ELUT Q3 2022 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$47M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-49.1% YoY

Gross Profit

$3M50.2% margin

Operating Income

-$9M-153.3% margin

Net Income

-$10M-169.4% margin

EPS (Diluted)

$-0.73

QoQ Revenue Growth

-53.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61M

Total Liabilities

$72M

Stockholders' Equity

-$11M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$11M	-49.1%
Gross Profit	$3M	$4M	-20.3%
Operating Income	-$9M	-$7M	-28.5%
Net Income	-$10M	-$8M	-19.2%